Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDG-PET/CT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06190574
What this trial is testing

Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma

Who this might be right for
18F-FDGNeuroblastomaHepatoblastoma+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Large-scale testing (Phase 3)WithdrawnNCT01652261
What this trial is testing

Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)

Who this might be right for
Hodgkin Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableStudy completedNCT07827482
What this trial is testing

Pretreatment 18F-FDG PET/CT Radiomics for Predicting Response to First-Line Targeted Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
First Affiliated Hospital of Fujian Medical University 228
Not applicableUnknownNCT05361135
What this trial is testing

18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia

Who this might be right for
Staphylococcus Aureus BacteremiaStaphylococcus Aureus SepticemiaSepsis Bacterial+4 more
University College, London 820
Not applicableStudy completedNCT03065725
What this trial is testing

Early Versus Late FDG-PET/CT in Bladder Cancer

Who this might be right for
Bladder Cancer
Jørgen Bjerggaard Jensen 179
Testing effectiveness (Phase 2)Looking for participantsNCT06103838
What this trial is testing

18F-Fluciclovine PET/CT in Multiple Myeloma

Who this might be right for
Multiple MyelomaNewly Diagnosed Multiple Myeloma (NDMM)Relapsed and/or Refractory Multiple Myeloma (RRMM)
National Cancer Institute (NCI) 60
Not applicableActive Not RecruitingNCT04667585
What this trial is testing

Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx

Who this might be right for
Oropharynx Cancer
Duke University 120
Not applicableStudy completedNCT02664792
What this trial is testing

Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer

Who this might be right for
Non-small Cell Lung Carcinoma
Latin American Cooperative Oncology Group 108
Not applicableStudy completedNCT02955966
What this trial is testing

PET/CT Guided Antifungal Stewardship in Invasive Pulmonary Aspergillosis

Who this might be right for
Aspergillosis and Haematological Malignancy
Assistance Publique - Hôpitaux de Paris 51
Not applicableUnknownNCT02928861
What this trial is testing

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Peking University Cancer Hospital & Institute 100
Not applicableUnknownNCT04272658
What this trial is testing

PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy

Who this might be right for
Metastatic Melanoma
University Hospital, Brest 56
Not applicableStudy completedNCT03561025
What this trial is testing

Diagnostic Potential of PET/MRI in Cardiac Sarcoidosis

Who this might be right for
SarcoidosisCardiomyopathies
St. Olavs Hospital 33
Very early researchNot Yet RecruitingNCT07007325
What this trial is testing

Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Carcinoma (SCLC)
Institut Cancerologie de l'Ouest 15
Not applicableActive Not RecruitingNCT04892667
What this trial is testing

Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, Hodgkin
Assistance Publique - Hôpitaux de Paris 128
Not applicableUnknownNCT03519659
What this trial is testing

Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT

Who this might be right for
PET/CT Imaging
University of Cincinnati 190
Large-scale testing (Phase 3)Ended earlyNCT06125028
What this trial is testing

[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
Pentixapharm AG 8
Testing effectiveness (Phase 2)UnknownNCT01576796
What this trial is testing

Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer

Who this might be right for
Stage III Non-small-cell Lung Cancer
Centre Henri Becquerel 75
Large-scale testing (Phase 3)UnknownNCT05111197
What this trial is testing

Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy

Who this might be right for
Locally Advanced Non Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer
Institut Cancerologie de l'Ouest 112
Post-approval studies (Phase 4)Study completedNCT01905566
What this trial is testing

Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque Inflammation

Who this might be right for
Plaque, Atherosclerotic
CHEOL WHAN LEE, M.D., Ph.D 50
Not applicableLooking for participantsNCT06795113
What this trial is testing

Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

Who this might be right for
Lymphoma
Ruijin Hospital 4,000
Next Page